surmount study tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Tirzepatide and blood pressure reduction:

The dedicated cardiovascular and renal outcomes trial of about 10,000 participants has not reported

One such peptide, MOTS-c (mitochondrial ORF of the 12S rRNA type-c), plays a role in regulating metabolic homeostasis, partly by regulating AMPK and mTOR pathways 7,8,10

This could be related to very low leptin levels in this model of CGL

This investigational peptide mimics the natural hormone amylin (also known as islet amyloid polypeptide or IAPP), which plays a crucial role in glucose homeostasis and satiety regulation [1]

It is not recommended for pregnant or breastfeeding women, and its safety and effectiveness in children have not been fully established